Consensus PetMed Express, Inc.

Equities

PETS

US7163821066

Real-time Estimate Cboe BZX 10:46:13 2024-04-24 am EDT 5-day change 1st Jan Change
4.14 USD -0.24% Intraday chart for PetMed Express, Inc. -2.13% -45.37%

Evolution of the average Target Price on PetMed Express, Inc.

Price target over the last 5 years

History of analyst recommendation changes

7a8b4b763a7c06ab4.MMxDiebHr6lYOo8psD_wBxXyi_s--JIUBh5_MJhM9Ik.Aag0zta_nps5S_tN4GeANySUv7hbkOZ2TUQJZ8wUluJZvC29hPea5Rx4yg~59c0bb1c5e05e28e8030842a37db7d6d
Morgan Stanley Trims Price Target on PetMed Express to $6.50 From $7, Keeps Underweight Rating MT
Morgan Stanley Cuts Price Target on PetMed Express to $7 From $10 After Fiscal Q2 Miss, Keeps Underweight Rating MT
Morgan Stanley Adjusts Price Target on PetMed Express to $10 From $17, Maintains Underweight Rating MT
Lake Street Initiates PetMed Express at Buy With $20 Price Target MT
Morgan Stanley Adjusts Price Target on PetMed Express to $17 From $18, Maintains Underweight Rating MT
Jefferies & Co Adjusts PetMed Express Price Target to $19 From $20, Maintains Hold Rating MT
Morgan Stanley Adjusts Price Target on PetMed Express to $18 From $19, Maintains Underweight Rating MT
Morgan Stanley Adjusts PetMed Express' Price Target to $19 from $20, Keeps Underweight Rating MT
Morgan Stanley Adjusts PetMed Express' Price Target to $20 from $21, Keeps Underweight Rating MT
Jefferies Lowers Price Target for PetMed Express to $24 From $26, Maintains Hold Rating MT
Morgan Stanley Cuts Price Target on PetMed Express to $21 From $25, Says Results Suggest 'Long Way to Go' With Turnaround; Underweight Kept MT
Sidoti Upgrades PetMed Express to Buy From Neutral; Price Target is $32 MT
Morgan Stanley Initiates PetMed Express at Underweight With $25 Price Target MT
PETMED EXPRESS : Jefferies Starts PetMed Express at Hold With $28 Price Target MT
PetMed Express : Shares Dive After Sidoti Stock Rating Downgrade MT
PETMED EXPRESS : Sidoti & Co Downgrades PetMed Express to Neutral From Buy, Keeps $39 Price Target MT
PETMED EXPRESS : Sidoti Upgrades PetMed Express to Buy From Neutral; Price Target is $41 MT
Petmed Express, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended September 30, 2018; Provides Effective Tax Rate Guidance for the Year 2019 CI
Petmed Express, Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended June 30, 2018; Provides Effective Tax Rate Guidance for the Year 2019 CI
Petmed Express, Inc. Reports Consolidated Unaudited Earnings Results for the Fourth Quarter and Year Ended on March 31, 2018; Provides Effective Tax Rate Guidance for the Full Year 2018 and 2019 CI
PetMed Express, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended December 31, 2017; Provides Effective Income Tax Rate Guidance for Three Months Ending March 31, 2018 and Full Fiscal Year 2019 CI
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
4.15 USD
Average target price
7.75 USD
Spread / Average Target
+86.75%
High Price Target
9 USD
Spread / Highest target
+116.87%
Low Price Target
6.5 USD
Spread / Lowest Target
+56.63%

Consensus detail

Consensus revision (last 18 months)

Analysts covering PetMed Express, Inc.

Morgan Stanley
Lake Street
Jefferies & Co.
Sidoti & Co.
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
  1. Stock Market
  2. Equities
  3. PETS Stock
  4. Consensus PetMed Express, Inc.